NCT00434512View on ClinicalTrials.gov

Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers

PHASE2CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

February 20, 2007

Primary Completion Date

June 13, 2008

Study Completion Date

June 13, 2008

Conditions

AIDSHIV Infections

Interventions

BIOLOGICAL

HIV vaccine 732461

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY